Aptamer Sciences Inc
KOSDAQ:291650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
KR |
|
CoDon AG
F:CNW
|
DE |
|
P
|
Paychex Inc
F:PCX
|
US |
|
BP PLC
LSE:BP
|
UK |
|
VentriPoint Diagnostics Ltd
F:5V7
|
CA |
|
CSL Ltd
ASX:CSL
|
AU |
|
Booking Holdings Inc
NASDAQ:BKNG
|
US |
|
ANTA Sports Products Ltd
HKEX:82020
|
CN |
|
I
|
Icade SA
SWB:3IC
|
FR |
|
T
|
Tesla Inc
F:TL0
|
US |
|
Y
|
Yoosung T&S Co Ltd
KOSDAQ:024800
|
KR |
|
E
|
EMnet Inc
KOSDAQ:123570
|
KR |
|
S
|
SGA Co Ltd
KOSDAQ:049470
|
KR |
|
Q
|
Qingling Motors Co Ltd
XMUN:QIN
|
CN |
|
O
|
Old National Bancorp
F:ON1
|
US |
|
N
|
NetApp Inc
XHAM:NTA
|
US |
|
Embotelladora Andina SA
NYSE:AKO.B
|
CL |
|
U
|
UniCredit SpA
OTC:UNCRY
|
IT |
|
Pico Far East Holdings Ltd
HKEX:752
|
HK |
|
M
|
Max's Group Inc
XPHS:MAXS
|
PH |
|
A
|
Adler Group SA
SWB:ADJ
|
LU |
|
P
|
PostNL NV
F:TNTC
|
NL |
|
H
|
Hanla IMS Co Ltd
KOSDAQ:092460
|
KR |
|
Tenaris SA
NYSE:TS
|
LU |
Bankruptcy Probability
Aptamer Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptamer Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
A
|
Aptamer Sciences Inc
KOSDAQ:291650
|
75.4B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
258.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
216.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
103.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptamer Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptamer Sciences Inc has total debt of 2B KRW. This includes both short-term (1.5B KRW) and long-term (419.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.